Stay updated on Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial

Sign up to get notified when there's something new on the Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Screenshots show only minor visual/layout adjustments with sections slightly rearranged; the substantive study information remains unchanged (overview, eligibility criteria, outcomes, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T21:03:55.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Major changes: updated operating status notice and a version bump to v3.2.0. Minor or no other content changes are indicated.
    Difference
    0.7%
    Check dated 2025-10-06T08:14:16.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0, indicating a new version release.
    Difference
    0.0%
    Check dated 2025-09-29T04:48:06.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed; overall, a minor UI/version update with no substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-14T22:12:25.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.0%
    Check dated 2025-09-07T19:24:30.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has updated its facility and location information, including the addition of new locations in Brazil and Mexico, while also revising the study's total number of locations from 30 to 29. Additionally, there is a new version revision noted.
    Difference
    1%
    Check dated 2025-08-31T12:25:42.000Z thumbnail image

Stay in the know with updates to Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of BNT162b2 in Immunocompromised ≥2yrs Clinical Trial page.